FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,737,000 | -13.0% | 568,382 | -3.8% | 0.00% | 0.0% |
| Q2 2022 | $14,637,000 | -48.4% | 590,679 | -19.2% | 0.00% | -40.0% |
| Q1 2022 | $28,346,000 | -30.8% | 731,125 | +4.5% | 0.01% | -28.6% |
| Q4 2021 | $40,943,000 | +13.1% | 699,752 | +14.6% | 0.01% | +16.7% |
| Q3 2021 | $36,186,000 | +66.1% | 610,540 | +143.2% | 0.01% | +50.0% |
| Q2 2021 | $21,785,000 | +46.4% | 251,005 | +39.1% | 0.00% | +33.3% |
| Q1 2021 | $14,878,000 | -15.8% | 180,448 | -7.1% | 0.00% | 0.0% |
| Q4 2020 | $17,663,000 | +2211.9% | 194,245 | +398.0% | 0.00% | – |
| Q4 2019 | $764,000 | -82.6% | 39,006 | -97.0% | 0.00% | -100.0% |
| Q4 2015 | $4,403,000 | -43.5% | 1,306,569 | -10.7% | 0.00% | -50.0% |
| Q3 2015 | $7,796,000 | -19.7% | 1,462,522 | -2.5% | 0.00% | -33.3% |
| Q2 2015 | $9,703,000 | +36.1% | 1,499,648 | +2.9% | 0.00% | +50.0% |
| Q1 2015 | $7,128,000 | -0.3% | 1,457,698 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $7,147,000 | -2.0% | 1,420,928 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $7,293,000 | -3.2% | 1,418,975 | +18.8% | 0.00% | 0.0% |
| Q2 2014 | $7,533,000 | -31.0% | 1,194,010 | +6.5% | 0.00% | -33.3% |
| Q1 2014 | $10,920,000 | +45.3% | 1,121,180 | -6.3% | 0.00% | +50.0% |
| Q4 2013 | $7,518,000 | – | 1,197,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $200,277,000 | 17.57% |
| Redmile Group, LLC | 12,957,222 | $767,975,000 | 13.39% |
| Copernicus Capital Management, LLC | 12,000 | $711,000 | 8.60% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $61,478,000 | 7.53% |
| DAFNA Capital Management LLC | 344,360 | $20,410,000 | 5.42% |
| Casdin Capital, LLC | 3,400,000 | $201,518,000 | 5.02% |
| Ally Bridge Group (NY) LLC | 270,000 | $16,003,000 | 4.70% |
| Darwin Global Management, Ltd. | 353,250 | $20,937,000 | 3.85% |
| Bellevue Group AG | 3,238,036 | $191,918,000 | 1.95% |
| Artal Group S.A. | 1,450,000 | $85,942,000 | 1.92% |